0.2813

0.21% -0.0067

Oragenics Inc (OGEN)

Overview News Price History Discussions Forecast Stock Split

Oragenics Inc stock is traded at $0.2813, with a volume of 83,885. It is down -0.21% in the last 24 hours and down -16.70% over the past month. Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.

Previous Close:

$0.288

Open:

$0.28

24h Volume:

83,885

Relative Volume:

0.15

Market Cap:

$3.29M

Revenue:

Net Income/Loss:

$-20.26M

P/E Ratio:

-0.0483

EPS:

-5.83

Net Cash Flow:

$-8.25M

1W Performance:

-12.62%

1M Performance:

-16.70%

6M Performance:

-90.55%

1Y Performance:

-91.79%

1-Day Range:

$0.265

$0.293

1-Week Range:

$0.2542

$0.35

52-Week Range:

$0.2542

$7.74

Oragenics Inc Stock (OGEN) Company Profile

Name

Oragenics Inc

Sector

Healthcare (1195)

Industry

Biotechnology (683)

Phone

813-286-7900

Address

4902 Eisenhower Boulevard, Suite 125, Tampa, FL

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

OGEN's Discussions on Twitter

Compare OGEN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OGEN	0.2875	3.29M	0	-20.26M	-8.25M	-5.83
VRTX	446.78	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	738.30	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	586.52	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.35	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.55	24.49B	3.30B	-501.07M	1.03B	11.54

Oragenics Inc Stock (OGEN) Latest News

Nov 19, 2024

OGEN Stock Plummets to 52-Week Low at $0.28 Amid Steep Decline - Investing.com Australia

Nov 19, 2024

Nov 13, 2024

OGEN stock plunges to 52-week low, touches $0.28 By Investing.com - Investing.com Australia

Oct 31, 2024

Oct 30, 2024

500: Something went wrong - Investing.com India

Oct 30, 2024

OGEN stock plunges to 52-week low, touches $0.28 - Investing.com

Oct 30, 2024

Oct 27, 2024

Oragenics (NYSE:OGEN) Now Covered by Analysts at StockNews.com - Defense World

Oct 27, 2024

Oct 24, 2024

Rare Disease Spotlight: Niemann-Pick pipeline behind two approvals - BioCentury

Oct 24, 2024

Oct 21, 2024

Oragenics, Inc. to Present at the Centurion One Capital 2nd Annual Bahamas Summit - Marketscreener.com

Oct 21, 2024

Oct 18, 2024

Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit - GlobeNewswire

Oct 18, 2024

Oct 16, 2024

Check Out Oragenics Inc (OGEN)’s Trade Data Rather Than the Analysts’ Views - SETE News

Oct 16, 2024

Oragenics Shares Investor Presentation Online - TipRanks

Oct 16, 2024

Oct 15, 2024

Oragenics inks sales agreement for at-the-market stock offering - Investing.com

Oct 15, 2024

Oragenics inks sales agreement for at-the-market stock offering By Investing.com - Investing.com South Africa

Oct 15, 2024